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1 PET/CT INFLUENCE ON CLINICAL MANAGEMENT
OF PATIENTS WITH PANCREATIC NEOPLASMS
Sperti C1, Pedrazzoli S4, Pasquali C1, Bissoli S2, Fiore V2, Scelzi E3,
Mion M3, (1) Medical and Surgical Sciences, Universita` di Padova,
Padova, Italy; (2) Nuclear Medicine, Castelfranco Veneto Hospital,
Treviso, Italy; (3) Medical Oncology, Castelfranco Veneto Hospital,
Treviso, Italy; (4) Clinica Chirurgica IV, Medical and Surgical
Sciences, Padova, Italy
INTRODUCTION AND AIM: Differential diagnosis of pancreatic
masses remains difficult despite the introduction of several technol-
ogies. Positron emission tomography (PET) has an emerging role
in the diagnosis and staging of different neoplasms, including
pancreatic adenocarcinoma. However, an exact anatomic delineation
of PET findings is often difficult. The integrated PET/CT scanner
provides the advantage of image fusion in the same examination,
improving the anatomic delineation of PET. The aim of this study
was to assess the impact of PET/CT on the management of patients
with suspected pancreatic tumors. PATIENTS AND METHODS:
From January 2004 to November 2004, 75 patients underwent PET/
CT examination for diagnosis and staging of suspected pancreatic
neoplasm (n=53) or during the follow-up after resection for
pancreatic cancer (n=22). All patients also underwent serum CA 19-
9 assay and abdominal ultrasonography. PET/CT examinations were
conducted according to standardized protocol following an injection
of 350–450 MBq FDG. All PET/CT findings were confirmed by
operation, biopsy or follow-up. RESULTS: There were 31 males and
44 females with a mean age of 61.1 years (range 37–80). In the group
of patients with suspected pancreatic tumor, the lesions were located
in the pancreatic head in 33, in the body in 10 and in the tail in 10
patients; in 19 cases there was a cystic lesion. In the final diagnosis,
25 patients had malignant tumors (24 adenocarcinomas and 1
lymphoma of the pancreas) and 28 a benign disease (12 serous
cystadenomas, 8 chronic pancreatitis, 6 intraductal mucinous
tumors, 2 undefined). Of the 26 PET-positive pancreatic lesions, 25
were malignant (positive predictive value 96%) and none of the
patients with PET-negative lesions had cancer (negative predictive
value of 100%). In 10 patients PET/CT showed distant metastases
not seen by conventional examinations in 6 patients. Moreover PET/
CT correctly identified as malignant 6 lesions with inconclusive
findings on traditional imaging. Two patients required additional
colic resection for simultaneous colon cancer not seen by conven-
tional staging. Of the 22 patients studied in the follow-up after
resection of primary tumor, recurrent disease occurred in 8 of whom
4 were only identified by PET/CT imaging (para-aortic lymph nodes
and liver). In one additional patient PET/CT correctly detected a
second primary colon carcinoma. Finally, the management was
changed in 15 patients (20%). CONCLUSION: The management
of patients with suspected primary or recurrent pancreatic cancer was
changed in one-fifth of patients, due to identification of malignancy,
unknown metastases or associated disease. We suggest the use of
PET/CT in the preoperative work-up of pancreatic neoplasms and in
the follow-up after resection of pancreatic adenocarcinoma.
2 PROSPECTIVE APPRAISAL OF MULTI-DETECTOR CT
IN SURGICAL DECISION MAKING FOR HILAR BILIARY
MALIGNANCIES
Uesaka K1, Maeda A1, Matsunaga K1, Kanemoto H1, Furukawa H2,
Morimoto N2, Aramaki T2, (1) Hepato-Biliary-Pancreatic
Surgery; (2) Diagnostic Image, Shizuoka Cancer Center Hospital,
Shizuoka, Japan
INTRODUCTION AND AIM: To prospectively evaluate the
usefulness of multi-detector computed tomography (MDCT) for
planning operative procedures in patients with hilar biliary malig-
nancies. PATIENTS AND METHODS: When a new patient with
malignant hilar stricture was referred to our hospital, MDCT was
performed on the first day. The study protocol of MDCT was a four-
phase acquisition beginning at 20, 40, 70, and 120 seconds after
contrast medium injection. The stage of the disease and treatment
plan were discussed at the hepato-biliary disease conference.
When the disease was judged as probably resectable, the operative
procedure was decided based on MDCT findings. Between
September 2002 and October 2004, 27 hilar biliary malignancies
were judged as probably resectable. Among them, 19 patients (hilar
cholangiocarcinoma 11, gallbladder cancer 4, intrahepatic bile duct
cancer 4) in whom biliary drainage had not been performed at the
time of MDCT were enrolled in this study. RESULTS: Of 19
probably resectable tumors, 18 were in fact resectable at surgery. The
operative procedures planned based on the MDCT findings were
performed in 17 of 18 resected cases (94% of the resected cases).
Curative resection with microscopic negative surgical margins was
done in 15 of 18 resected cases (83%). The cause of noncurative
resection in three cases was positive surgical margin by mucosal
cancer at the proximal bile duct stump. CONCLUSION: MDCT
before biliary drainage may provide reliable information for assess-
ment of cancer extent except mucosal carcinoma and planning
operative procedures in patients with hilar biliary malignancies.
3 CT-GUIDED PERCUTANEOUS DRAINAGE OF
SOLITARY AND MULTIPLE PYOGENIC LIVER ABSCESSES:
AN EFFECTIVE AND LOW COST THERAPY
Thanos L1, Mylona S1, Hristofidis T2, Ellinas P1, Fragiskou N1,
Karaliotas K2, Batakis N1, (1) Radiology, Red Cross Hospital;
(2) Surgical, Red Cross Hospital, Athens, Greece
INTRODUCTION AND AIM: Untreated pyogenic liver abscesses
are almost uniformly fatal. Traditionally, treatment consists of anti-
biotic administration and drainage of purulent collections. In this
report, therefore, we compared the characteristics of the patients and
the efficacy of CT-guided percutaneous drainage (CT-PD) between
solitary and multiple abscesses. PATIENTS AND METHODS:
CT-guided percutaneous drainage was carried out in 108 patients
with pyogenic liver abscesses. The abscesses were solitary in 97
patients and multiple (2–5) in 11 patients. 12–14F catheters were
used for continuous irrigation. Multiple catheters were used in 5
patients with large and multiple pyogenic liver abscesses. RESULTS:
Biliary diseases were more frequently observed in the solitary cases
than multiple cases. The most frequent organims were E. coli,
Streptococcus, Klebsiella pneumoniae and Salmonella spp. E. coli was
more frequently cultured from the abscesses in the multiple cases. In
2 cases, it was not possible to bacteriologically identify the germs. All
the solitary cases were successfully treated. The average duration of
CT-PD was 12 days. CONCLUSION: CT-guided percutaneous
drainage is a highly effective method in solitary or multiple pyogenic
liver abscesses. Surgical drainage is more likely to be required in
patients who have abscess rupture, incomplete percutaneous drain-
age or uncorrected primary pathology.
4 CYSTIC PANCREATIC TUMOR: DIAGNOSIS WITH
SPIRAL CT AND PERCUTANEOUS CT-GUIDED BIOPSY
Mylona S1, Thanos L1, Papakonstantinou T2, Fragiskou N1, Ellinas
P1, Batakis N1, Karaliotas K2, (1) Radiology, Red Cross Hospital;
(2) Surgical, Red Cross Hospital, Athens, Greece
INTRODUCTION AND AIM: Cystic pancreatic tumors account
1–3% of all pancreatic neoplasms and 10–13% of cystic pancreatic
lesions. They are divided into two groups: microcystic adenoma and
macrocystic adenoma, which have significantly different therapeutic
and prognostic implications. This study evaluates the diagnostic
value of spiral CT and CT-guided biopsy for the confirmation of
these types of lesions. PATIENTS AND METHODS: In 4 years 33
patients having cystic lesions in pancreas without known clinical
history of pancreatitis underwent triple phase spiral CT (without and
with IV contrast) and CT-guided biopsy (FNA 22 and CNB 18). The
infusion protocol of contrast was: flow rate: 5 ml/s, scan delay: 20 s
(1st phase) and 50 s (2nd phase), total volume: 125–150 ml. We
evaluated the size, location and morphology of these lesions.
RESULTS: Specific diagnosis before surgery was achieved with
CNB in 24 (72.7%) patients. Characterization of lesion with CT
findings was possible in 20 (60.6%). In 4 (12.12%) and 8 (24.24%)
patients we had incorrect or non-specific diagnosis, respectively.
We had no complications from the biopsies. The final diagnosis
was: serous cystadenoma (5), mucinous cystadenocarcinoma (13),
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intraductal adenocarcinoma with cystic degeneration (1), cystic islet
cell tumor (1), pseudocyst (2), epithelial cyst (2). CONCLUSION:
Spiral CT and CT-guided biopsy is an up-to-date method for the
confirmation and characterization of cystic pancreatic tumors. The
exact diagnosis before surgery reduces morbidity and mortality.
5 PREOPERATIVE STAGING OF PANCREATIC
CARCINOMA: IS DUAL-PHASE SPIRAL CT ADEQUATE
FOR THE CONFIRMATION OF ITS RESECTABILITY?
Mylona S1, Thanos L1, Sgourakis G2, Fragiskou N1, Hristofidis T2,
Batakis N1, Karaliotas K2, (1) Radiology, Red Cross Hospital;
(2) Surgical, Red Cross Hospital, Radiology, Athens, Greece
INTRODUCTION AND AIM: To present the value of dual-phase
spiral CT for the confirmation of resectability and preoperative
staging of pancreatic carcinoma. PATIENTS AND METHODS: In
a period of 4 years 184 patients with pancreatic carcinoma underwent
dual-phase spiral CT for preoperative staging. CT scans after IV
administration of contrast material with an electronic injector were
obtained at the arterial (scan delay=20 s) and at the portal venous
phase (scan delay=50 s) under a protocol with total volume=
150 ml, flow rate 5 ml/s. We correlated the CT findings with
surgical-pathologoanatomic findings. RESULTS: Dual-phase spiral
CT was positive for pancreatic carcinoma in 178 patients (96.7%). In
6 patients results were was false-positive (3.3%). 44 (78.4%) of 55
patients showed hepatic metastases, 33 (64.7%) of 51 patients
showed lymph node enlargement, 49 (88%) of 60 patients had
vascular invasion and 8 (66.6%) of 12 patients had peritoneal
metastases. The accuracy of the method was up to 90%.
CONCLUSION: Dual-phase spiral CT is a safe, noninvasive, and
accurate method to investigate pancreatic carcinoma and should be
considered as the standard preoperative method for assessing lesion
resectability.
6 DIAGNOSTIC VALUE OF ULTRASOUND FOR
DETECTION OF LOCAL RECURRENCE FOLLOWING
RADIOFREQUENCY ABLATION IN THE LIVER
Eisele RM1, Schumacher G1, Lopez-Ha¨nninen E2, Spinelli A3,
Neuhaus P1, (1) General, Visceral & Transplantation Surgery,
Charite Virchow Clinic, Berlin; (2) Radiology, Charite´ Virchow
Clinic, Berlin, Germany; (3) General Surgery, Istituto Clinico
Humanitas, Milan, Italy
INTRODUCTION AND AIM: Ultrasound has proven to be useful
in imaging radiofrequency ablation (RFA) lesions intra- and post-
operatively. The presented study intended to prove the value of
ultrasound examination as a means of screening RFA-treated
patients for local tumor recurrence. PATIENTS AND METHODS:
Since February 2001, 91 RFA treatments in 61 patients have been
performed in our department. Indications for RFA were HCC
(74%), colorectal metastases (18%), recurrent CCC (5%), and one
NET as well as one metastasis of pancreatic cancer (each 1.5%). RFA
was only considered in non-resectable liver cancer. Each application
was sonographically guided following preoperative evaluation.
Postoperative screening included sonographic examinations at
intervals of 3, 6 and 12 months postoperatively and further annual
follow-up examinations. Mean follow-up period was 11.8 months.
RESULTS: Within the first 12 months after the treatment, the
lesions become more and more inhomogeneous with mixed echo-
geneity. Occasionally, this evolves as a misleading finding mimicking
early tumor recurrence. In suspicious cases (31%), magnetic reso-
nance imaging (20%) or computed tomography (11%) was engaged
to clarify the situation. Ultrasound led to detection of local tumor
recurrence in 78% of recurrent HCC (10 patients), but just in 67% of
metastatic disease (3 patients). Overall local recurrence rate was
14%. CONCLUSION: At least in primary hepatic malignant
disease, ultrasound screening as a follow-up, in spite of low specifity,
is sufficient for detecting early local recurrence due to high sensitivity.
Further imaging techniques should be engaged in confirming suspi-
cious lesions.
7 POSSIBILITIES OF ULTRASOUND HISTOGRAPHY
IN DIAGNOSIS OF CHRONIC ALCOHOLIC
PANCREATITIS (CAP)
Gubergrits NB, Belyayeva N, Chair of the Internal Diseases No 1,
Donetsk State Medical University, Donetsk, Ukraine
INTRODUCTION AND AIM: CAP sonographic signs are
nonspecific and their evaluation has subjective and empirical
character. Aim: to increase informative capacity of pancreas sono-
graphy in CAP. PATIENTS AND METHODS: We examined
92 CAP patients, in whom the following indices of ultrasound
histography were analyzed: B—the width of histogram basis; S—
initial interval (segment from level of gray corresponding to “1” to
the first histogram elements); L—level of gray most typical for
examined area. These data were a basis for calculation of histographic
index I. 30 healthy persons were also examined. RESULTS: In
indurative-obstructive variant of CAP index I was 0.42+0.09, in
parenchymatous 1.92+0.11 and in healthy 0.96+0.12. In both
CAP variants index I was reliably different between variants of the
disease and from normal level as well. So I allows not only diagnosis
of the disease, but lets us differentiate clinical variants of CAP.
Sensitivity of index I in CAP was 98.9%, while traditional sono-
graphy was 72.0%. CONCLUSION: Ultrasound histography
(histographic index) increases the informative capacity of sonography
in CAP diagnostics.
8 THE IMPACT OF INTRAOPERATIVE
ULTRASONOGRAPHY (IOUS) IN LIVER SURGERY
Shukla PJ1, Shrikhande SV1, Pandey D1, Rao PP2, Thakur MH2,
Arya S2, Ramani S2, Kanitkar GA1, Mehta S3, Mohandas KM3,
(1) GI Surgical Oncology, Tata Memorial Hospital; (2) Department
of Radio-Diagnosis, Tata Memorial Hospital; (3) Department of
Digestive Diseases & Clinical Nutrition, Parel, Mumbai, India
INTRODUCTION AND AIM: Intraoperative ultrasonography
(IOUS) during surgery for primary and metastatic hepatic tumors
identifies additional lesions and helps in determining the most opti-
mal surgical strategy. In this study, we assess the impact of IOUS in
liver surgery at the Tata Memorial Hospital, a tertiary cancer centre
in India. This is the first study on IOUS reported from India.
PATIENTS AND METHODS: Patients with potentially resectable
hepatic tumors underwent surgical exploration. IOUS was
performed and relationship of the tumor with regard to the intra-
hepatic vasculature was determined. A search was also made for
additional lesions not detected by preoperative imaging modalities.
In appropriate cases, IOUS was also used to assist resection and
radiofrequency ablation. RESULTS: Between January 2003 and
September 2004, 41 patients underwent surgery for hepatic lesions.
IOUS detected additional hepatic lesions in 11 patients (24.4%).
IOUS was directly responsible for avoiding resection or radio-
frequency ablation in 7 patients (17.1%), 5 of whom had multiple
bilobar lesions, 1 had IOUS-guided biopsy which revealed caseating
granuloma on frozen section (thus obviating the need of resection/
ablation), and 1 patient had no lesion on IOUS. IOUS also guided
radiofrequency ablation in 8 patients and assisted in resection in 30
patients. CONCLUSION: IOUS is an essential tool in surgery for
hepatic tumors. In addition to accurate staging, it also aids in safe
resection and radiofrequency ablation in appropriate cases.
9 THE UTILITY OF 99M Tc-MEBROFENIN
SCINTIGRAPHY IN EVALUATING LIVER STEATOSIS
IN A RAT MODEL
Vetela¨inen R2, Bennink R1, DeBruin C1, van VlietA2, van Gulik T2,
(1) Nuclear Medicine; (2) Surgery, Surgical Laboratory, Academic
Medical Center, Amsterdam, The Netherlands
INTRODUCTION AND AIM: There are no noninvasive methods
to evaluate the progress and severity of steatosis. This study evaluates
the utility of 99mTc-mebrofenin scintigraphy in correlating hepatic
function with structural changes related to steatosis and steato-
hepatitis in a rat model. PATIENTS AND METHODS: Wistar
rats (250–300 g) were fed a methione- and choline-deficient diet
(MCDD) inducing hepatic steatosis and steatohepatitis at 1, 3, 5 and
7 weeks (n=4 per time point). Baseline controls were also used
(n=4). 99mTc-mebrofenin pinhole scintigraphy was used to evalu-
ate the hepatocyte 99mTc-mebrofenin uptake rate and the time of
maximal uptake (Tmax). The hepatic uptake was correlated with
hepatocellular damage (ALT, AST/ALT ratio), synthesis function
(prothrombin time: PT-TT), inflammation (TNF-alpha in plasma
and liver), hepatic triglycerides and with histopathology (steatosis,
inflammation, fibrosis in H&E and Oil Red stains). RESULTS:
MCDD diet induced steatosis after 1 week and steatohepatitis after 5
weeks with typical pathological features (increased inflammatory
activity, mild fibrosis). Tmax was significantly slower in steatotic rats
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(p50.05). There was a strong correlation between the severity of
steatosis and 99mTc-mebrofenin uptake rate (r=0.82, p50.0001),
the uptake rate decreased significantly when the severity of steatosis
increased. 99mTc-mebrofenin uptake rate also correlated indepen-
dently with plasma and hepatic TNF-alpha (r=0.72, p50.0001 and
r=0.52, p=0.0001, respectively), with hepatic triglycerides content
(r=0.82, p50.0001) and with PT-TT (r=0.07, p50.001). The
correlation of uptake rate with ALT and AST/ALT ratio was weak
(r=0.32 and r=0.29). CONCLUSION: 99mTc-mebrofenin uptake
rate correlates strongly with severity of steatosis and steatohepatitis,
suggesting the utility of 99mTc-hepatobiliary scintigraphy as a
noninvasive method for monitoring disease progression in steatosis
and steatohepatitis.
10 SPLANCHNIC PSEUDOANEURYSMS: A CASE REPORT
Joshi RM1, Palep JH1, Sanjanwala SS1, Sonawane AU1, Zawar VS1,
Darveshi PJ1, Rajpal KL2, (1) General Surgery; (2) Interventional
Radiology, LTM Medical College & General Hospital, Mumbai,
India
INTRODUCTION AND AIM: We describe the presentation and
management of splanchnic arterial pseudoaneurysms in two patients.
PATIENTS AND METHODS: One of the patients presented with
intermittent haematemesis and melaena along with acute upper
abdominal pain due to pancreatitis and due to cholecystitis in the
other patient. Diagnosis in each case was confirmed by a CT
angiogram. RESULTS: While the first patient could be successfully
treated with transcatheter embolisation of the gastroduodenal artery,
the other patient with pseudoaneurysm of the cystic artery required
emergency surgical intervention. CONCLUSION: Splanchnic
arterial pseudoaneurysms, other than those of the splenic artery
secondary to pancreatitis, are extremely uncommon. The gastro-
duodenal artery and pancreaticoduodenal arteries are less commonly
affected. Even rarer are pseudoaneurysms of the hepatic artery. The
complexity of the anatomical location makes surgical treatment
hazardous. Transcatheter embolization is a definitive minimally
invasive form of treatment and surgical treatment is necessitated only
when this fails.
11 CONTRAST-ENHANCED INTRAOPERATIVE
ULTRASONOGRAPHY DURING HEPATECTOMIES FOR
PRIMARY AND METASTATIC TUMORS: RESULTS IN A
PROSPECTIVE COHORT OF PATIENTS
Torzilli G, Palmisano A, Del Fabbro D, Donadon M, Rottoli M,
Montorsi M, 3rd Department of Surgery, Istituto Clinico
Humanitas, Rozzano – Milan, Italy
INTRODUCTION AND AIM: Preliminary reports showed that
contrast-enhanced intraoperative ultrasonography (CE-IOUS) is
feasible and seems to add important information to that provided
with conventional intraoperative ultrasonography (IOUS). The aim
of this study is to validate the impact of CE-IOUS in resective surgery
for primary and secondary liver tumors PATIENTS AND METH-
ODS: Between September 2003 and November 2004, 57 consecu-
tive patients underwent liver resection using IOUS and CE-IOUS.
There were 35 males and 22 females and mean patient age was 65.6
years (median 67; range 36–87). 34 patients had HCC, and 23
colorectal cancer (CRC) liver metastases. CE-IOUS was accom-
plished injecting intravenously 2.4 ml of sulphur-hexafluoride
microbubbles. RESULTS: CE-IOUS provided new information in
21 patients out of 57 (37%). In patients with HCC, it did not confirm
as malignant the new nodules detected by IOUS in 7 patients, it
confirmed the malignancy of part of the new nodules detected by
IOUS in 4 and in the remaining 2 it fully confirmed as HCC the
additional lesions detected by IOUS. In patients with CRC liver
metastases, CE-IOUS disclosed new lesions missed at preoperative
imaging and at IOUS in 4 patients, which accounted for 17% of all
patients with CRC liver metastases, and confirmed all the additional
lesions detected by IOUS in the remaining 3 patients. Additionally,
CE-IOUS helped in defining the tumor margins of the main lesion in
5 of 23 patients (22%). CONCLUSION: These results show that
IOUS accuracy is improved by CE-IOUS with a significant impact
on surgical strategy and radicality.
12 18-FDGPET ISVERYUSEFUL INTHEDIAGNOSISAND
MANAGEMENT OF NONPANCREATIC PERIAMPULLARY
NEOPLASMS
Sperti C1, Pedrazzoli S4, Pasquali C1, Chierichetti F2, Liessi G3,
(1) Scienze Mediche e Chirurgiche, Universita` di Padova, Padova;
(2) Nuclear Medicine, Castelfranco Veneto Hospital, Treviso, Italy;
(3) Radiology, Castelfranco Veneto Hospital, Treviso, Italy;
(4) Clinica Chirurgica IV, Scienze Mediche e Chirurgiche, Padova,
Italy
INTRODUCTION AND AIM: 18-Fluorodeoxyglucose positron
emission tomography (18-FDG PET) has been investigated for
diagnosis and staging of gastrointestinal malignancies including
pancreatic adenocarcinoma. However, its role in the clinical
management of nonpancreatic periampullary tumors has not been
studied so far. The aim of this study was to examine the clinical
impact of 18-FDG PET in the diagnosis and follow-up of patients
with periampullary neoplasms. PATIENTS AND METHODS: 23
patients (14 males and 9 females, mean age 65.1 years, range 41–83)
underwent whole-body 18-FDG PET and abdominal computer
tomography (helical CT). In all patients malignant or benign disease
was confirmed pathologically after surgery. The 18-FDG PET was
analyzed visually and semi-quantitatively using the standard uptake
value (SUV). Positivity was assumed when a focal uptake occurred
with a SUV of at least 2.5. RESULTS: There were 14 ampullary
tumors (9 adenocarcinomas and 5 adenomas), 7 bile duct neoplasms
(6 adenocarcinomas and 1 carcinoma in situ), and 2 duodenal tumors
(1 adenocarcinoma and 1 leiomyoma). 18 patients underwent
pancreaticoduodenectomy, 2 local excision, and 3 bypass surgery.
18-FDG PET showed increased focal uptake in 20 patients (87%):
11/14 (79%) of ampullary tumors, and 100% of bile duct and
duodenal tumors. 18-FDG PET showed focal uptake in 11/12
patients without detectable mass at CT scan. 18-FDG PET showed
also lymph node metastases in 5 patients. SUV value of 2.7 discrim-
inated adenomas or noninvasive cancers (n=6) from invasive
malignancies (n=14). Follow-up including CT and 18-FDG PET
was performed in 8 patients: 18-FDG PET showed recurrent disease
not seen by CT in 4 patients, confirmed CT findings in 3. A patient
underwent resection of the recurrence, 2 patients underwent pallia-
tive surgery, 4 patients did not undergo surgery. Finally a primary
lung cancer was detected by 18-FDG PET and resected.
CONCLUSION: 18-FDG PET showed high sensitivity for detect-
ing periampullary neoplasms. 18-FDG PET may be useful in clinical
practice when no mass has been identified by traditional imaging, to
differentiate benign or borderline lesions from invasive tumors, and
in the follow-up to identify recurrent disease.
13 THE DIAGNOSIS OF DUCT DISRUPTION AND
PANCREATIC LEAK WITH DYNAMIC SECRETIN
STIMULATED MRCP
Kurzawinski TR2, Gillams A1, Lees B1, (1) Department of
Radiology; (2) HPB & Endocrine Surgery, Middlesex Hospital,
London, UK
INTRODUCTION AND AIM: Pancreatic duct disruption (PDD)
and presence of pancreatic leak (PL), are significant factors influ-
encing outcome and choice of the treatment in patients with
pancreatic trauma and pancreatitis. This study assesses the role of
secretin MRCP (sMRCP) in patients with suspected PDD and PL.
PATIENTS AND METHODS: 17 patients (13 M, 4F) mean age
39 yrs (range 10–71) with complicated pancreatitis (9), blunt
abdominal trauma (5) and iatrogenic injury (3) underwent MRCP
before and after 0.1 ml/kg IV Secretin (Sanochemia, Germany).
Diagnostic criteria for PDD and PL were (a) parenchymal continuity
and lacerations, (b) duct size before and after Secretin, (c) location
and increase in the size and signal intensity of peripancreatic fluid
collections after Secretin. sMRCP findings were correlated with
clinical outcome and choice of conservative or interventional treat-
ment at a mean follow-up of 6 months (range 2–54). RESULTS:
There were no complications after sMRCP. 10/17 patients had PDD
and PL on sMRCP. 6 had surgery and 1 endoscopic stenting with
resolution of symptoms. Out of 3 patients with PL on sMRCP treated
conservatively, 1 showed resolution on a 2nd sMRCP. 2 others
continued to have problems for several months. sMRCP was negative
in 7 patients, 5 responded to conservative therapy and 2 had surgery
(1 duct obstruction and pain, 1 false negative result). Sensitivity of
sMRCP in predicting need for intervention was 78%. CONCLU-
SION: Secretin MRCP is a safe noninvasive test which helps to
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diagnose PDD and PL and select patients for either interventional or
conservative treatment.
14 FLUORODEOXYGLUCOSE PET IN THE EVALUATION
OF BILIARY TRACT CARCINOMA
Furukawa H1, Endo M1, Uesaka K2, (1) Diagnostic Radiology;
(2) Hepato-Pancreatico-Biliary Surgery, Shizuoka Cancer Center
Hospital, Shizuoka, Japan
INTRODUCTION AND AIM: The aim is to evaluate the utility
of positron emission tomography with [18F]-labeled fluorodeoxy-
glucose (FDG) for staging of primary possibly resectable cholan-
giocarcinoma (CC) and gallbladder carcinoma (GBC) and for
detection of recurrence of those tumors. PATIENTS AND
METHODS: Patients with CC (n=41), with GBC (n=19), and
with benign lesions of the bile ducts (n=5) underwent FDG-PET
(200–250 MBq [18F]-FDG, GE ADVANCE NXi) and whole-body
multidetector row computed tomography (MDCT). RESULTS:
For staging of primary tumors, true-positive FDG-PET scans were
obtained in a total of 41 (89%) of all malignant lesions (30 of 35 CC
and 11 of GBC). FDG-PET was positive for 20 (95%) of 21 nodular
tumors, but for 11 (73%) of 15 infiltrating tumors. MDCT detected
in the total of 44 (96%) of all malignant lesions (33 of 35 CC and all
11 GBC). The FDG-PET scan was true-negative in all 5 benign
lesions. The sensitivity, specificity, and accuracy of FDG-PET for
regional lymph node metastases were 38%, 100%, and 73%, while
those of MDCT were 50%, 81%, and 71%, respectively. Distant
metastases were diagnosed in all 4 cases on FDG-PET, whereas 3 of
4 on MDCT. The sensitivity, specificity, and accuracy of FDG-PET
for detection of recurrence were 100%, 100%, and 100%, while those
of MDCT were 83%, 75%, and 79%, respectively. CONCLUSION:
PET is highly sensitive and specific for the detection of primary and
recurrent CC and GBC. It can be helpful for detection of distant
metastases but is not suitable for detection of regional lymph node
metastases.
15 NEW ANATOMY OF THE LIVER REGARDING
PORTAL SEGMENTATION AND DRAINAGE VEIN
Ryu M, Cho A, Takayama W, Kobayashi S, Sugaya M, Hanari N,
Surgery, Chiba Prefectural Sawara Hospital, Sawara, Japan
INTRODUCTION AND AIM: Couinaud divided the right liver
into four segments (S5, S6, S7, and S8). This classification proposed
by Couinaud is widely accepted but we have experienced so many
differences between Couinaud’s anatomy and 3-D image anatomy
during surgery. PATIENTS AND METHODS: We evaluated the
portal segmentation of the right anterior and posterior segment of the
liver by using helical CT during arterial portography. Material was 84
patients without tumor or cirrhosis. RESULTS: The right anterior
portal trunk does not bifurcate into P8 and P5. In all cases, the right
anterior portal trunk bifurcated into ventralis and dorsalis, which
were equal in size. All drainage veins of the antero-ventral area join
the middle hepatic vein. All drainage veins of the antero-dorsal area
joined the right hepatic vein. The hepatic vein crossing between the
ventral and dorsal areas is always observed. In 70% of cases, antero-
ventral region, antero-dorsal and posterior segments were similar size
in volume. CONCLUSION: Regarding portal segmentation and
liver volume, right liver should be divided into 3 segments as antero-
ventral segment, antero-dorsal segment, and posterior segment.
16 Tc99m CIPROFLOXACIN IMAGING IN ACUTE
CHOLECYSTITIS
Ahn SI2, Choe W1, Cho EH2, Lee KY2, (1) Department of Nuclear
Medicine, Gachon Medical School, Incheon; (2) Department of
Surgery, Inha University Hospital, Incheon, South Korea
INTRODUCTION AND AIM: Diagnosis of acute cholecystitis has
been made by ultrasonography or biliary scintigraphy. In this study,
we introduce a new nuclear imaging for Tc-99m ciprofloxacin
(infection) in the diagnosis of acute cholecystitis and evaluate its
efficacy. PATIENTS AND METHODS: Sixteen patients thought to
have acute cholecystitis were included in this study. All of them
underwent surgical intervention with laparoscopic or open chole-
cystectomy after undergoing ultrasonographic and nuclear imaging
study. The final diagnosis of acute cholecystitis was made by clinical
symptoms and ultrasonographic and pathologic findings. We
analyzed the correlations between the histological findings of the
gallbladder, clinical findings and nuclear images. RESULTS: Among
16 patients, 12 patients were diagnosed as acute cholecystitis and 4 as
chronic cholecystitis. Twelve patients were image-positive. Among
them, 11 patients were finally diagnosed as acute cholecystitis, and
one was false positive. Four patients were image-negative. Among
them, three were true negative, and one was false negative. This
nuclear imaging had a sensitivity of 91.7% (11/12), a specificity of
75% (3/4), positive predictive value of 91.7% (11/12), and negative
predictive value of 75% (3/4). No adverse reaction occurred
following the administration of the radiopharmaceutical to patients.
CONCLUSION: Tc-99m ciprofloxacin imaging is easy and appli-
cable for the diagnosis of acute cholecystitis.
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